Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
InspireMD Inc
NSPRCurrent price
2.37 USD
-0.04 USD (-1.66%)
Last closed
2.36 USD
Company
www.inspiremd.com
ISIN
US45779A8466
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
77 813 664 USD
Yield for 12 month
+3.04 %
1Y
3Y
5Y
10Y
15Y
NSPR
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida. Address: 6303 Waterford District Drive, Miami, FL, United States, 33126
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.75 USDP/E ratio
–Dividend Yield
–Current Year
+7 009 000 USD
Last Year
+6 205 000 USD
Current Quarter
+1 949 000 USD
Last Quarter
+1 810 000 USD
Current Year
+1 506 000 USD
Last Year
+1 807 000 USD
Current Quarter
+469 000 USD
Last Quarter
+414 000 USD
Key Figures NSPR
1 year
3 years
5 years
10 years
EBITDA
-33 223 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-44.34 %
PEG Ratio
–
Return On Equity TTM
-84.68 %
Wall Street Target Price
4.75 USD
Revenue TTM
7 009 000 USD
Book Value
1.36 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
10.70 %
Dividend Yield
–
Gross Profit TTM
1 506 000 USD
Earnings per share
-0.76 USD
Diluted Eps TTM
-0.76 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NSPR
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History NSPR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:15
Payout Ratio TTM
–
Last Split Date
27.04.2021
Stock Valuation NSPR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
11.70
Enterprise Value Revenue
7.19
Price Sales TTM
11.80
Enterprise Value EBITDA
0.52
Price Book MRQ
2.29
Financials NSPR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NSPR
For 52 weeks
2.07 USD
3.80 USD
50 Day MA
2.79 USD
Shares Short Prior Month
240 060
200 Day MA
2.74 USD
Short Ratio
3.70
Shares Short
191 929
Short Percent
0.86 %
BeatStart